The value of rapid functional assays of germline p53 status in LFS and LFL families

British Journal of Cancer

Volumn 82, Issue 6, 2000, Pages 1145-1148

  Camplejohn, R S ^a   Sodha, N ^b   Gilchrist, R ^a   Lomax, M E ^a   Duddy, P M ^a   Miner, C ^d   Alarcon Gonzalez, P ^d   Barnes, D M ^c   Eeles, R A ^b  

^a ST THOMAS HOSPITAL   (United Kingdom)

^b INSTITUTE OF CANCER RESEARCH   (United Kingdom)

^c GUY S HOSPITAL   (United Kingdom)

^d UNIVERSITY OF VALLADOLID   (Spain)

Author keywords

Apoptosis; FASAY; Li Fraumeni syndrome; P53

Indexed keywords

DNA; PROTEIN P53;

APOPTOSIS; ARTICLE; ASSAY; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEVICE; DNA SEQUENCE; EXON; FAMILIAL CANCER; GENE MUTATION; GENETIC SCREENING; HEALTH CARE COST; HUMAN; HUMAN CELL; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE;

APOPTOSIS; BASE SEQUENCE; BIOLOGICAL ASSAY; FEMALE; GENES, P53; GENETIC SCREENING; GERM-LINE MUTATION; HUMANS; MALE; MOLECULAR SEQUENCE DATA; NEOPLASMS; REPRODUCIBILITY OF RESULTS; RISK ASSESSMENT;

EID: 0034052306     PISSN: 00070920     EISSN: None     Source Type: Journal    
DOI: 10.1054/bjoc.1999.1054     Document Type: Article

References (10)

1. Birch JM, Hartley AL, Tricker KJ, Prosser J, et al (1994) Prevalence and diversity of constitutional mutations in the p53 gene among 21 Li-Fraumeni families. Cancer Res 54: 1298-1304
2. Campiejohn RS, Perry P, Hodgson SV, Turner G, et al (1995) A possible screening test for inherited p53-related defects based on the apoptotic response of peripheral blood lymphocytes to DNA damage. Br J Cancer 72: 654-662
3. Casey G, Lopez ME, Ramos JC, Plummer SJ, et al (1996) DNA sequence analysis of exons 2 through 11 and immunohistochemical staining are required to detect all known p53 alterations in human malignancies. Oncogene 13:1971-1981
4. Eeles RA (1995) Germline mutations in the TP53 gene. Cancer Surv 25: 101-124
5. Flaman JM, Frebourg T, Moreau V, Charbonnier F, et al (1995) A simple p53 functional assay for screening cell lines, blood and tumours, Proc Natl Acad Sci USA 92: 3963-3967
6. Li FP and Fraumeni JF (1969) Soft-tissue sarcomas, breast cancer and other neoplasms. Ann Int Med 71: 747-752
7. Lomax ME, Barnes DM, Gilchrist R, Picksley SM, Varley JM and Camplejohn RS (1997) Two functional assays employed to detect an unusual mutation in the oligomerisation domain of p53 in a Li-Fraumeni like family. Oncogene 14: 1869-1874
8. Malkin D, Li FP, Strong LC, Fraumeni JF, et al (1990) Germline p53 mutations in a familial syndrome of breast cancer, sarcomas and other neoplasms. Science 250: 1233-1238
9. Varley JM, Mcgown G, Thorncroft M, Santibanezkoref MF, Kelsey AM, Tricker KJ, Evans DGR and Birch JM (1997) Germ-line mutations of TP53 in Li-Fraumeni families: An extended study of 39 families. Cancer Res 57: 3245-3252
10. Varley JM, Chapman P, Mcgown G, Thorncroft M, et al (1998) Genetic and functional studies of a germline TP53 splicing mutation in a Li-Fraumeni-like family. Oncogene 16:3291-3298